Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 07 Aug 2024

Establishment of a chemokine-based prognostic model and identification of CXCL10+ M1 macrophages as predictors of neoadjuvant therapy efficacy in colorectal cancer

in Cancer Immunity and Immunotherapy

Abudumaimaitijiang Tuersun
Jianting Huo
Zeping Lv
Yuchen Zhang
Fangqian Chen
Jingkun Zhao
Wenqing Feng
Zhuoqing Xu
Zhihai Mao
Pei Xue

Frontiers in Immunology

doi 10.3389/fimmu.2024.1400722

2,570 views
1 citation

Case Report

Published on 07 Aug 2024

Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC

in Cancer Immunity and Immunotherapy

Nicolas Roussot
Marion Thibaudin
Jean-David Fumet
Susy Daumoine
Léa Hampe
Cédric Rébé
Emeric Limagne
Aurélie Lagrange
Victor Herreros
Julie Lecuelle

Frontiers in Immunology

doi 10.3389/fimmu.2024.1437961

1,723 views

Original Research

Published on 07 Aug 2024

Association of immune evasion in myeloid sarcomas with disease manifestation and patients’ survival

in Cancer Immunity and Immunotherapy

Marcus Bauer
Astrid Monecke
Hubert Hackl
Andreas Wilfer
Nadja Jaekel
Hendrik Bläker
Haifa Kathrin Al-Ali
Barbara Seliger
Claudia Wickenhauser

Frontiers in Immunology

doi 10.3389/fimmu.2024.1396187

1,349 views

Original Research

Published on 06 Aug 2024

Deciphering breast cancer prognosis: a novel machine learning-driven model for vascular mimicry signature prediction

in Cancer Immunity and Immunotherapy

Xue Li
Xukui Li
Bin Yang
Songyang Sun
Shu Wang
Fuxun Yu
Tao Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1414450

1,571 views
1 citation

Original Research

Published on 06 Aug 2024

Development and validation of a hypoxia- and mitochondrial dysfunction- related prognostic model based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer

in Cancer Immunity and Immunotherapy

Yirong Li
Yue Cui
Zhen Wang
Liwei Wang
Yi Yu
Yuyan Xiong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419133

3,461 views
1 citation

Review

Published on 06 Aug 2024

The modification role and tumor association with a methyltransferase: KMT2C

in Cancer Immunity and Immunotherapy

Yunjuan Jiao
Yuanhao Lv
Mingjie Liu
Yun Liu
Miaomiao Han
Xiwen Xiong
Hongyan Zhou
Jiateng Zhong
Xiaohong Kang
Wei Su

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444923

3,425 views
1 citation

Review

Published on 05 Aug 2024

TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression

in Cancer Immunity and Immunotherapy

Banglu Wang
Fan Zhang
Xiaoyu Wu
Mei Ji

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433321

2,032 views
1 citation

Correction

Published on 05 Aug 2024

Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

in Cancer Immunity and Immunotherapy

Longsha Liu
Thijs A. van Schaik
Kok-Siong Chen
Filippo Rossignoli
Paulo Borges
Vladimir Vrbanac
Hiroaki Wakimoto
Khalid Shah

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466387

744 views

Original Research

Published on 05 Aug 2024

Exercise-augmented THSD7B exhibited a positive prognostic implication and tumor-suppressed functionality in pan-cancer

in Cancer Immunity and Immunotherapy

Zhiwen Luo
Jinguo Zhu
Zhengyuan Fang
Rui Xu
Renwen Wan
Yanwei He
Yisheng Chen
Shuo Chen
Qing Wang
Qizhi Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1440226

2,635 views
3 citations

Mini Review

Published on 05 Aug 2024

Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance

in Cancer Immunity and Immunotherapy

Xiaolin Wu
Nuan Feng
Chao Wang
Hongfei Jiang
Zhu Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444452

1,766 views
5 citations

Review

Published on 05 Aug 2024

The current status and future of targeted-immune combination for hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Liyuan Hao
Shenghao Li
Fanghang Ye
Hengyi Wang
Yuxin Zhong
Xiaoyi Zhang
Xiaoyu Hu
Xiaopeng Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1418965

4,326 views
5 citations

Original Research

Published on 05 Aug 2024

Plasma extracellular vesicle long RNA profiling identifies a predictive signature for immunochemotherapy efficacy in lung squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Xin Zhang
Jiatao Liao
Wenyue Yang
Qiaojuan Li
Zhen Wang
Hui Yu
Xianghua Wu
Huijie Wang
Si Sun
Xinmin Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421604

1,604 views

Original Research

Published on 05 Aug 2024

Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8+ cytotoxic T cell recruitment to pancreatic tumours

in Cancer Immunity and Immunotherapy

Patrick Freeman
Gaia Bellomo
Lucy Ireland
Maidinaimu Abudula
Teifion Luckett
Michael Oberst
Ruth Stafferton
Paula Ghaneh
Chris Halloran
Michael C. Schmid

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382538

2,032 views

Review

Published on 02 Aug 2024

The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy

in Cancer Immunity and Immunotherapy

Kosuke Murakami
Sudipto Ganguly

Frontiers in Immunology

doi 10.3389/fimmu.2024.1441730

3,548 views
1 citation

Systematic Review

Published on 02 Aug 2024

Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Huipeng Fang
Qiao Ke
Shiji Wu
Qiang Tu
Lei Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421520

2,126 views
1 citation

Original Research

Published on 02 Aug 2024

Development and validation of a survival prediction model for patients with advanced non-small cell lung cancer based on LASSO regression

in Cancer Immunity and Immunotherapy

Yimeng Guo
Lihua Li
Keao Zheng
Juan Du
Jingxu Nie
Zanhong Wang
Zhiying Hao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1431150

2,659 views
2 citations

Navigation group

Articles

Establishment of a chemokine-based prognostic model and identification of CXCL10+ M1 macrophages as predictors of neoadjuvant therapy efficacy in colorectal cancer

Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC

Association of immune evasion in myeloid sarcomas with disease manifestation and patients’ survival

Deciphering breast cancer prognosis: a novel machine learning-driven model for vascular mimicry signature prediction

Development and validation of a hypoxia- and mitochondrial dysfunction- related prognostic model based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer

The modification role and tumor association with a methyltransferase: KMT2C

TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression

Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Exercise-augmented THSD7B exhibited a positive prognostic implication and tumor-suppressed functionality in pan-cancer

Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance

The current status and future of targeted-immune combination for hepatocellular carcinoma

Plasma extracellular vesicle long RNA profiling identifies a predictive signature for immunochemotherapy efficacy in lung squamous cell carcinoma

Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8+ cytotoxic T cell recruitment to pancreatic tumours

The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy

Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis

Development and validation of a survival prediction model for patients with advanced non-small cell lung cancer based on LASSO regression